Risk of recalls and product discontinuations due to adverse effects and quality issues
First written in FY2017. 1 of 3 entries say "Mitigated", first in FY2021. Latest entry: FY2022.
5 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「As measures, the Company has introduced a Quality Management Review for quality control and has established a specialised unit within the reliability assurance department to monitor and confirm the possibility of foreseeable quality problems.」
The Company continues to use Quality Management Review and monitoring and confirmation by a specialised unit as measures addressing quality problems. - FY2021MitigatedAnnual report
「As measures, the Company has introduced a Quality Management Review for quality control and has established a specialised unit within the reliability assurance department to monitor and confirm the possibility of foreseeable quality problems.」
Quality Management Review and monitoring and confirmation by a specialised unit are stated as measures addressing the risks of adverse effects and quality problems. - FY2017First statedAnnual report
「Unexpected adverse effects after products are placed on the market, incidents such as contamination of products with impurities, or regulations imposed by regulatory authorities may force the recall of products or the discontinuation of their manufacture or sale.」
The risks of recalls and the discontinuation of manufacturing and sales due to post-marketing adverse effects, contamination with impurities and regulatory requirements are stated.